Anaplasmosis

Anaplasmosis is a significant tick-borne infectious disease affecting cattle caused by the rickettsial organism Anaplasma marginale, and less commonly Anaplasma centrale. This blood-borne pathogen specifically targets red blood cells, leading to their destruction and causing progressive anemia that can range from mild to life-threatening depending on the animal's age, immune status, and the speed of diagnosis and treatment. The disease occurs worldwide in tropical and subtropical regions where suitable tick vectors are present, though it has also established itself in temperate climates through mechanical transmission by biting flies and contaminated equipment.

Anaplasmosis affects cattle of all breeds, though the severity of clinical signs varies considerably with age. Calves under one year of age typically experience mild or subclinical infections due to passive immunity from colostrum and an age-related resistance factor. However, cattle over two years of age are highly susceptible to severe clinical disease and death if left untreated. The disease is particularly problematic in endemic areas where naive adult cattle are introduced, as these animals lack any natural immunity and often develop acute, severe infections. Prevalence rates in endemic regions can exceed fifty percent of the cattle population, with many animals becoming chronic carriers after recovery.

The economic impact of anaplasmosis on cattle operations is substantial and multifaceted. Direct losses include mortality rates that can reach thirty percent or higher in untreated adult cattle, decreased milk production in dairy herds, weight loss and poor condition in beef cattle, and reproductive losses including abortion in pregnant cows. Indirect costs include treatment expenses, diagnostic testing, implementation of control programs, and movement restrictions in some regions. The disease also creates significant management challenges as recovered animals often become lifelong carriers capable of serving as reservoirs for new infections within the herd.

Early detection and treatment of anaplasmosis significantly improves outcomes and reduces economic losses. The disease is highly treatable when caught in the early stages before severe anemia develops, with tetracycline antibiotics being effective against the causative organism. However, advanced cases with profound anemia carry a guarded prognosis due to the risk of complications during treatment. Prevention through tick control, vaccination where available, and careful management of carrier animals remains the cornerstone of anaplasmosis control in endemic areas. Producers should work closely with their veterinarians to develop comprehensive herd health programs that address this important disease.

The primary cause of anaplasmosis is infection with the rickettsial organism Anaplasma marginale, an obligate intracellular pathogen that specifically infects bovine red blood cells. This microscopic organism is transmitted between cattle primarily through the bite of infected tick vectors, with over twenty species of ticks identified as capable of transmitting the disease. In North America, the primary tick vectors include Dermacentor species such as Dermacentor andersoni and Dermacentor variabilis, while other regions may have different predominant vector species. The organism can also be transmitted mechanically by biting flies, including horse flies and stable flies, which transfer infected blood between animals on their mouthparts.

Mechanical transmission through contaminated equipment represents a significant and often overlooked cause of anaplasmosis spread within herds. Any instrument that contacts the blood of an infected animal and is then used on susceptible cattle can transmit the organism. Common sources of iatrogenic transmission include needles, dehorning equipment, castration instruments, ear taggers, tattooing equipment, and nose tongs. Even small amounts of blood can contain sufficient organisms to establish infection, making proper sanitation and the use of single-use needles essential components of disease prevention.

Environmental and management factors play crucial roles in determining anaplasmosis risk within cattle operations. Herds located in endemic areas with high tick populations face ongoing exposure pressure, particularly during warm months when vector activity peaks. The introduction of carrier animals into naive herds represents a major risk factor, as these clinically normal animals serve as reservoirs of infection. Similarly, moving naive cattle into endemic areas without proper vaccination or preventive treatment commonly results in disease outbreaks. Grazing management practices that expose cattle to tick-infested pastures and brush areas increase transmission risk substantially.

Age is the most significant risk factor influencing the severity of anaplasmosis in individual animals. Young calves under approximately one year of age possess both passive immunity from colostrum and an intrinsic age-related resistance that typically limits clinical disease to mild or inapparent infections. This inverse age-immunity relationship means that cattle first exposed as adults develop the most severe clinical disease. Animals that recover from infection develop strong immunity against clinical disease but become chronic carriers, with organisms persisting in their bloodstream at low levels for years or even for life. Stress, concurrent disease, and nutritional deficiencies can exacerbate clinical signs and increase susceptibility to severe disease.

The pathophysiology of anaplasmosis involves invasion and multiplication of Anaplasma marginale within red blood cells, leading to their destruction and removal by the spleen. Unlike some hemolytic diseases, anaplasmosis does not cause intravascular hemolysis but rather results in extravascular destruction of parasitized and non-parasitized erythrocytes. This process leads to progressive anemia, with the packed cell volume often dropping to critically low levels in severe cases. The anemia triggers compensatory responses including increased heart rate and respiratory rate, but these mechanisms can become overwhelmed in acute cases, leading to tissue hypoxia, weakness, and potentially death.

Early warning signs of anaplasmosis are often subtle and easily overlooked, particularly in herds where the disease is not commonly encountered. Initial symptoms typically appear seven to sixty days after infection, with an average incubation period of approximately thirty days. The earliest signs include mild lethargy, decreased appetite, and slight separation from the herd. Affected cattle may show reduced grazing activity and spend more time resting in shaded areas. Body temperature may be mildly elevated in the early stages, though fever is inconsistent and not a reliable early indicator. Observant producers may notice a subtle decline in milk production in dairy cattle or condition loss in beef animals before more obvious signs develop.

As the disease progresses, symptoms become more pronounced and easier to identify. The hallmark clinical sign of anaplasmosis is progressive anemia, which manifests as pale or yellowish discoloration of the mucous membranes, including the gums, conjunctiva, and vulvar mucosa. The yellow coloration, known as icterus or jaundice, results from the breakdown of hemoglobin released from destroyed red blood cells and accumulation of bilirubin in tissues. Affected cattle develop increasing weakness and exercise intolerance, often lagging behind the herd when moved and showing reluctance to walk or stand for extended periods.

Behavioral changes in cattle with anaplasmosis reflect the physiological stress of severe anemia. Infected animals typically separate from the herd and seek shade and water sources, showing marked depression and decreased responsiveness to stimuli. Appetite decreases significantly as the disease advances, and cattle may stand with their heads lowered and ears drooped. Constipation is common, with affected cattle producing small, dry fecal balls. In some cases, cattle may display unusual aggression or excitability, particularly when stressed or handled, which has earned the disease the colloquial name galloping fever in some regions. This aggression results from cerebral hypoxia secondary to severe anemia.

Physical examination of cattle with clinical anaplasmosis reveals characteristic findings beyond the obvious anemia and icterus. Heart rate is typically elevated, often exceeding one hundred beats per minute, as the cardiovascular system attempts to compensate for reduced oxygen-carrying capacity. Respiratory rate similarly increases, with cattle showing visible increased respiratory effort during even minimal exertion. Pregnant cows may abort, particularly in the latter stages of gestation, due to fetal hypoxia. Dehydration develops as affected cattle reduce water intake, and weight loss becomes apparent as the disease progresses over days to weeks.

The progression of anaplasmosis symptoms follows a predictable pattern if left untreated. Following the incubation period, acute clinical signs develop over several days to two weeks. The packed cell volume drops progressively, often reaching levels below twelve percent in severe cases compared to the normal range of thirty to forty percent. At this stage, affected cattle are in critical condition and may die suddenly, particularly if stressed or excited. Death typically results from acute heart failure as the oxygen-starved heart muscle can no longer maintain adequate circulation. The mortality rate in untreated clinical cases can reach thirty percent or higher in adult cattle.

Emergency symptoms requiring immediate veterinary intervention include profound weakness or inability to rise, extremely pale or white mucous membranes indicating severe anemia, rapid shallow breathing, cold extremities, and collapse. Any stressed handling of severely anemic cattle can precipitate fatal cardiac arrest. Pregnant cattle showing signs of anaplasmosis should receive immediate attention due to the high risk of abortion. Cattle found dead with signs of anemia and icterus should prompt immediate investigation and testing of herd mates, as additional cases are likely present given the transmission dynamics of the disease.

Clinical examination provides the initial basis for suspecting anaplasmosis in affected cattle. Veterinarians evaluate mucous membrane color, heart and respiratory rates, body condition, and hydration status to assess disease severity. The combination of progressive anemia, icterus, and fever in adult cattle, particularly in endemic areas or following tick exposure, is highly suggestive of anaplasmosis. However, clinical signs alone cannot definitively distinguish anaplasmosis from other causes of hemolytic anemia, making laboratory confirmation essential for accurate diagnosis and appropriate treatment decisions.

Diagnostic testing for anaplasmosis employs several complementary methods. Blood smear examination remains a rapid and accessible diagnostic tool, with Giemsa or Wright-stained thin blood smears examined microscopically for the presence of Anaplasma marginale organisms within red blood cells. The organisms appear as small, round, densely-staining bodies typically located at the margin of infected erythrocytes, hence the species name marginale. However, parasitemia levels fluctuate, and blood smears may be negative in early infections or chronic carriers despite active infection. Complete blood count reveals regenerative anemia with decreased packed cell volume and hemoglobin concentration, often accompanied by increased reticulocyte counts as the bone marrow responds to red cell destruction.

Advanced diagnostic methods provide more sensitive and specific detection of anaplasmosis infection. Serological testing using competitive enzyme-linked immunosorbent assay or card agglutination tests detects antibodies against Anaplasma marginale, useful for identifying previous exposure and carrier animals. However, antibody tests cannot distinguish between current and past infections. Polymerase chain reaction testing offers the most sensitive method for detecting active infection by identifying organism DNA in blood samples, capable of detecting carriers with very low parasitemia that would be missed on blood smear examination. This molecular testing has become increasingly important for screening breeding stock and identifying carrier animals for management purposes.

Differential diagnosis of anaplasmosis must consider other causes of hemolytic anemia and icterus in cattle. Babesiosis, another tick-borne disease caused by Babesia species, produces similar clinical signs and often occurs in the same geographic regions. Leptospirosis can cause hemolysis and icterus, particularly in calves. Copper toxicity, bacillary hemoglobinuria caused by Clostridium haemolyticum, and various toxic plants capable of causing hemolysis must also be considered. Accurate diagnosis through laboratory testing guides appropriate treatment selection and informs control measures, as management approaches differ significantly between these conditions.

Emergency treatment of acute anaplasmosis focuses on eliminating the organism while supporting the severely anemic animal through the critical period. Tetracycline antibiotics represent the mainstay of treatment, with oxytetracycline being most commonly used at a dosage of eleven milligrams per kilogram body weight administered intramuscularly or intravenously. Treatment should be initiated as soon as anaplasmosis is suspected, as delays allow further red blood cell destruction and worsen prognosis. In severely affected cattle, the initial antibiotic injection should be given with minimal handling and stress, as excitement can precipitate fatal cardiac arrest in profoundly anemic animals.

Medical management extends beyond antibiotic therapy to address the physiological consequences of severe anemia. Blood transfusions may be necessary for cattle with packed cell volumes below ten percent, providing immediate improvement in oxygen-carrying capacity while the animal's bone marrow regenerates red blood cells. Transfusion should use compatible donor blood, ideally from a cow that has recovered from anaplasmosis and is no longer in the acute phase. Intravenous fluid therapy helps maintain hydration and supports cardiovascular function. Importantly, all treatments for cattle intended for meat or milk production must account for withdrawal times, which typically range from twenty-eight days for oxytetracycline in meat cattle and ninety-six hours for milk, though specific products may vary.

Supportive care for anaplasmosis cases significantly influences recovery outcomes. Affected cattle should be moved to a shaded, quiet area with easy access to fresh water and palatable feed. Any handling or movement should be minimized and conducted slowly and calmly to avoid stress-induced cardiac events. Cattle should not be forced to walk long distances while severely anemic. Protection from temperature extremes is important, as anemic animals have reduced thermoregulatory capacity. Concurrent conditions such as parasitism, nutritional deficiencies, or secondary infections should be addressed, as these can impair recovery and worsen outcomes.

Imiquimod clearance protocols have been developed for situations where complete elimination of carrier status is desired, such as in breeding bulls or animals being exported to non-endemic areas. These protocols typically involve multiple treatments with high doses of tetracyclines combined with imidocarb dipropionate, which has anaplasmacidal activity. However, clearance is not always achievable, and repeated testing is necessary to confirm success. In most commercial situations, the focus remains on treating clinical disease rather than eliminating carrier status, as carrier animals develop immunity and serve as sources of endemic stability.

Herd treatment protocols become necessary when multiple cases of anaplasmosis occur. Strategic treatment of all at-risk cattle with long-acting oxytetracycline preparations can reduce mortality during outbreaks while vector control measures are implemented. Injectable oxytetracycline at twenty milligrams per kilogram body weight provides therapeutic blood levels for several days. Alternatively, chlortetracycline can be fed at labeled dosages to provide continuous low-level protection, though this does not eliminate infection. Decisions regarding which animals to treat should consider disease stage, economic value, and practical feasibility.

Treatment decisions in farm animal practice inherently involve economic considerations alongside animal welfare concerns. The cost of treatment, including drugs, veterinary services, and labor, must be weighed against the animal's value and probability of recovery. Severely affected cattle with packed cell volumes below eight percent have guarded to poor prognoses even with aggressive treatment. In some cases, humane euthanasia may be the most appropriate option, particularly for commercial cattle with limited individual value and poor prognosis. These difficult decisions should involve consultation between producers and veterinarians, considering both economic realities and ethical obligations to animal welfare.

Recovery timeline from anaplasmosis varies considerably depending on disease severity at the time treatment is initiated. Cattle with mild to moderate anemia that receive prompt treatment typically show improvement within forty-eight to seventy-two hours, with appetite returning and activity levels increasing. However, regeneration of red blood cells to normal levels requires several weeks, as the bone marrow must produce sufficient new erythrocytes to replace those destroyed during the infection. Packed cell volume may take three to four weeks to return to normal range, and cattle should be monitored during this period to ensure continued improvement.

Post-treatment care focuses on supporting red blood cell regeneration and preventing complications. Adequate nutrition is essential, with particular attention to iron, copper, and B-vitamin intake, which are necessary for hemoglobin synthesis and erythropoiesis. High-quality forage and appropriate supplementation support the metabolic demands of recovery. Cattle should be protected from stressors during the recovery period, including extreme weather, long-distance transport, and intensive handling. Gradual return to normal activity helps prevent cardiopulmonary stress while oxygen-carrying capacity remains below normal.

Prognosis following anaplasmosis depends primarily on the degree of anemia at presentation and the speed of treatment initiation. Cattle treated when packed cell volumes remain above twelve percent generally have good prognoses with expected full recovery. Those with packed cell volumes between eight and twelve percent have fair prognoses with appropriate treatment, though recovery is prolonged. Cattle presenting with packed cell volumes below eight percent have guarded prognoses, and mortality may occur despite aggressive treatment. Pregnant cows that survive the acute phase should be monitored for abortion in the weeks following infection.

Return to production following anaplasmosis recovery requires consideration of several factors. Meat withdrawal periods must be observed for any treated animals, with the specific timeframe depending on the drugs used. Dairy cattle should have milk withheld for the appropriate period following treatment. Recovered cattle become immune to clinical disease but remain chronic carriers, meaning they will have Anaplasma marginale organisms persisting in their blood at low levels indefinitely. These carrier animals are protected against future clinical disease but can serve as sources of infection for susceptible herd mates through tick or mechanical transmission. Understanding carrier status is important for herd management and movement decisions.

Vaccination represents a cornerstone of anaplasmosis prevention in endemic areas where disease pressure is significant. Several vaccine products are available, including killed vaccines containing Anaplasma marginale antigens and live vaccines using the less pathogenic Anaplasma centrale strain. Killed vaccines require annual administration and provide protection against severe clinical disease while allowing animals to develop immunity through controlled natural exposure. Live Anaplasma centrale vaccines, where permitted, provide broader protection but carry some risk of causing mild clinical disease. Vaccination programs should be implemented before the peak transmission season and coordinated with other herd health procedures for efficiency.

Biosecurity measures form the foundation of anaplasmosis control on cattle operations. Preventing the introduction of carrier animals into naive herds requires testing of all incoming cattle, including breeding stock, stocker cattle, and show animals. Serological or PCR testing can identify carriers, allowing informed decisions about introduction or segregation. Quarantine of new arrivals for at least thirty days with testing before release into the main herd reduces introduction risk. Operations that commingle cattle from multiple sources, such as stocker operations, face particular challenges and should consider prophylactic treatment protocols.

Vector control reduces anaplasmosis transmission by limiting tick exposure and biting fly populations. Tick control methods include strategic application of pour-on acaricides, injectable avermectins with acaricidal activity, and ear tags containing acaricides. Treatment timing should coincide with peak tick activity periods for maximum effectiveness. Pasture management practices such as controlled burning, mowing, and brush control reduce tick habitat. Biting fly control through traps, premise sprays, and on-animal insecticides limits mechanical transmission. Integrated pest management approaches combining multiple methods provide more effective and sustainable vector control than reliance on any single technique.

Management practices significantly influence anaplasmosis risk independent of vector control. Using single-use needles for all injections eliminates iatrogenic transmission through contaminated needles, a common source of within-herd spread. Similarly, disinfection of surgical instruments, dehorning equipment, and other blood-contaminated tools between animals prevents mechanical transmission. Separating known carrier animals from susceptible cattle, particularly during high-transmission seasons, reduces exposure. Age-at-exposure management, when feasible, allows young calves to develop immunity through natural exposure while protected by age-related resistance.

Quarantine and testing protocols are essential for operations moving cattle between endemic and non-endemic regions. Animals exported from endemic areas should be tested and possibly treated to eliminate carrier status, depending on importing region requirements. Cattle entering endemic areas from non-endemic regions should be vaccinated before arrival and monitored closely for clinical signs during the initial exposure period. Many countries and states have specific regulatory requirements for anaplasmosis testing related to cattle movement, and producers should be familiar with applicable regulations for their operations and intended markets.

Daily management of cattle herds in anaplasmosis-endemic areas requires ongoing vigilance and systematic monitoring. Regular observation of cattle for early signs of illness, including separation from the herd, decreased appetite, and lethargy, allows prompt identification of affected animals before severe anemia develops. Mucous membrane color should be assessed routinely during handling procedures, providing baseline information and enabling detection of developing anemia. During high-transmission seasons, typically warm months when tick and fly activity peaks, observation frequency should increase. Producers should maintain a high index of suspicion for anaplasmosis and establish relationships with veterinarians capable of providing rapid diagnostic and treatment services.

Housing and environmental management contribute to anaplasmosis control through multiple mechanisms. Providing shade and shelter protects cattle from temperature extremes that stress anemic animals and attracts cattle to areas where tick exposure may be reduced. Drainage improvements and vegetation management in and around facilities reduce tick habitat and breeding sites. Processing facilities should be designed to allow calm, low-stress handling, particularly important for managing anemic cattle where excitement can be fatal. Isolation facilities for sick animals allow intensive monitoring and treatment while preventing stress from herd interactions.

Herd health programs for anaplasmosis integrate preventive measures with surveillance and response protocols. Annual vaccination schedules should be established for herds in endemic areas, with timing coordinated to provide protection before peak transmission seasons. Vector control programs should be planned on a seasonal basis, with products and methods selected based on local vector species and resistance patterns. Protocols for testing incoming cattle and responding to clinical cases should be documented and understood by all personnel. Working relationships with diagnostic laboratories ensure rapid access to testing when needed.

Record keeping supports effective anaplasmosis management through multiple mechanisms. Individual animal records should document vaccination history, testing results, clinical episodes, and treatments, enabling identification of chronic carriers and tracking of disease patterns. Herd-level records of disease incidence, mortality, treatment costs, and production impacts allow assessment of control program effectiveness and economic analysis. Monitoring trends over time helps identify emerging problems and evaluate changes in management practices. Electronic record systems facilitate analysis and enable data sharing with veterinary advisors.

Economic considerations permeate all aspects of anaplasmosis management in commercial cattle operations. Prevention costs, including vaccination, vector control products, testing, and biosecurity measures, must be balanced against potential losses from clinical disease, mortality, reduced production, and treatment expenses. The optimal level of investment in prevention depends on local disease pressure, herd susceptibility, cattle values, and operational characteristics. Endemic stability, where carrier cattle provide reservoir infection that maintains herd immunity through ongoing low-level exposure, may represent the most cost-effective approach in some situations, while aggressive carrier elimination may be appropriate for seedstock operations or cattle destined for export to non-endemic regions.

All breeds of cattle are susceptible to anaplasmosis infection, but disease severity and outcomes vary based on several factors. Bos taurus breeds, including European breeds such as Angus, Hereford, Holstein, and other dairy and beef breeds developed in temperate climates, generally experience more severe clinical disease than Bos indicus breeds when infected as adults. This difference reflects both the longer evolutionary association between Bos indicus cattle and the disease in tropical environments and the inherent tick resistance of many Bos indicus breeds, which reduces exposure. Crossbred cattle with Bos indicus influence often demonstrate intermediate susceptibility.

Production type influences anaplasmosis impact and management approaches within affected herds. Dairy cattle face particular challenges because the disease affects animals during their productive lives and causes significant milk production losses. High-producing dairy cows are often more susceptible to clinical disease due to metabolic stress associated with lactation. Beef cattle operations must consider the disease's impact on weight gain, reproductive performance, and mortality when evaluating control strategies. Seedstock operations face additional concerns related to carrier status and buyer expectations, often necessitating more aggressive testing and control measures.

Genetic selection for anaplasmosis resistance remains limited compared to selection for tick resistance, though the two traits are related. Breeds and individual animals with greater tick resistance experience reduced exposure to Anaplasma-infected ticks, thereby reducing infection risk. Incorporating Bos indicus genetics into herds in endemic tropical regions provides both tick resistance and apparent tolerance to anaplasmosis when infection occurs. Research continues into genetic markers for disease resistance, but practical selection tools are not yet widely available. Currently, management practices including vaccination, vector control, and controlled exposure remain the primary tools for reducing disease impact across all breeds.

Babesiosis frequently co-occurs with anaplasmosis in cattle, as both diseases share tick vectors and geographic distributions. The combination of these two hemolytic diseases, sometimes called tick fever complex, can produce more severe clinical signs than either disease alone. Cattle infected with both pathogens experience accelerated red blood cell destruction and may deteriorate rapidly. Diagnostic testing should consider both diseases when hemolytic anemia is detected in cattle from endemic areas, as treatment protocols differ and accurate diagnosis guides appropriate therapy.

Several conditions produce clinical signs similar to anaplasmosis and must be considered in the differential diagnosis. Theileriosis, caused by various Theileria species, causes anemia and lymph node enlargement in cattle and is transmitted by ticks. Leptospirosis can cause hemolysis, icterus, and fever, particularly in young cattle, though renal and reproductive signs are often prominent. Bacillary hemoglobinuria, caused by Clostridium haemolyticum, produces acute hemolysis in cattle on liver fluke-infested pastures. Copper toxicity causes acute hemolytic crisis following release of accumulated hepatic copper, typically in sheep but occasionally in cattle under specific circumstances.

Complications of anaplasmosis extend beyond the acute hemolytic episode and influence long-term animal health. Abortion occurs in a significant percentage of pregnant cows with clinical anaplasmosis, with losses concentrated in the latter half of gestation. Recovered cattle may experience prolonged poor performance as red cell mass gradually returns to normal. Carrier animals remain chronically infected for life and can experience recrudescence of clinical signs during periods of stress or immunosuppression. Secondary bacterial infections may occur in debilitated animals. Cardiac damage from severe anemia may result in reduced exercise tolerance, though this has not been extensively documented in cattle.